{"id":33279,"date":"2020-08-12T15:07:42","date_gmt":"2020-08-12T14:07:42","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=33279"},"modified":"2021-03-18T12:32:30","modified_gmt":"2021-03-18T12:32:30","slug":"jorg-engelbergs","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/","title":{"rendered":"J\u00f6rg Engelbergs"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n<h2>J\u00f6rg Engelbergs, PhD<\/h2>\n<h4>Scientific Regulatory Expert Biomedicines at Paul-Ehrlich-Institut (PEI), Federal Institute for Vaccines and Biomedicines<\/h4>\n\t<div class=\"su-expand su-expand-collapsed su-expand-link-style-default\" data-height=\"400\"><div class=\"su-expand-content su-u-trim\" style=\"color:#333333;max-height:400px;overflow:hidden\">\n<p>Dr.&nbsp;J\u00f6rg Engelbergs is currently working for the Paul-Ehrlich-Institut in Langen, Germany, as regulatory-scientific expert and assessor (Quality \/ CMC and Non-Clinic) for biopharmaceuticals with focus on Biotechs (Monoclonal Antibodies) and further as expert for IVDs \/ biomarker based Companion Diagnostics (CDx) and stratified \/ personalized (Bio-) Medicines.<\/p>\n<p>He is involved in the European process of market authorization of biopharmaceuticals, comprising scientific assessments and national \/ EMA advices. Further activities are assessments of GCP conformity of clinical phase I-III trials, national and third-country (USA, East Asia) GMP inspections, and experimental research on biomarkers.<\/p>\n<p>Dr. Engelbergs is member of the Pharmacogenomics Working Party (PGWP) at the European Medicines Agency (EMA), London, UK. He is also member of the Host-Cell Protein (HCP) Working Party and of the P4Bio Working Party at the European Directorate for the Quality of Medicines &amp; HealthCare (EDQM), Strasbourg, France. Further he is member of the German Society for Research on DNA Repair (DGDR).<\/p>\n<p>Dr. Engelbergs holds a Diploma in biology and a PhD in cell biology and biotechnology. Before Dr. Engelbergs joined the PEI, he has gained large experience in experimental cancer research and neuropharmacology research.<\/p>\n<p>In this time he was head of \u201cNeuropharmacology laboratory\u201d with focus on triptan-, targeted monoclonal antibody &amp; antisense therapy and therapy resistance for auto-immune diseases and with focus on development of diagnostic and predictive biomarkers for personalized medicines. In parallel he was head of the clinical core \u201cGenotyping service center\u201d (SNP, mutation and expression profiling) both at Department of Neurology at University of Essen Medical School, Germany.<\/p>\n<p>Before, he has been scientific project leader in various experimental cancer research projects with focus on DNA Repair, mutagenesis, carcinogenesis, chemotherapy &amp; therapy resistance, biomarker development and targeted monoclonal antibody therapy. In parallel he has been also head of the core \u201cMonoclonal antibody research and production unit\u201d both at Institute of Cell Biology (Cancer Research) [IFZ] at the West German Cancer Center (WTZE).<\/p>\n<\/div><div class=\"su-expand-link su-expand-link-more\" style=\"text-align:left\"><a href=\"javascript:;\" style=\"color:#0088FF;border-color:#0088FF\"><span style=\"border-color:#0088FF\">Show more<\/span><\/a><\/div><div class=\"su-expand-link su-expand-link-less\" style=\"text-align:left\"><a href=\"javascript:;\" style=\"color:#0088FF;border-color:#0088FF\"><span style=\"border-color:#0088FF\">Show less<\/span><\/a><\/div><\/div>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit_2.png\" alt=\"Engelbergs_Jorg_BioTech_Pharma_Summit_2\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Engelbergs_Jorg_BioTech_Pharma_Summit_2\" onerror=\"this.style.display='none'\" sizes=\"(max-width: 768px) 100vw, 100vw\" srcset=\"data:image\/svg+xml;utf8,<svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/>&#8221; data-srcset=&#8221;https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit_2.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit_2-201&#215;300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit_2-686&#215;1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit_2-768&#215;1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit_2-630&#215;940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit_2-420&#215;627.png 420w&#8221;>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Scientific-Regulatory Challenges for Co-Development of Drug and Companion Diagnostics in Europe\n\t<\/h3>\n<ul>\n<li>Overview of current CDx regulatory requirements in the EU<\/li>\n<li>Challenges and requirements for analytical assay validation during clinical development<\/li>\n<li>Considerations on complex (multimarker) assays<\/li>\n<li>Ensuring diagnostic assay quality during clinical drug-Dx co-development and clinical routine<\/li>\n<\/ul>\n\t<a href=\"\" target=\"_blank\" role=\"button\" rel=\"noopener noreferrer\">\n\t\t\t\t\tPresentation not available\n\t<\/a>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.pei.de\/EN\/home\/node.html\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.pei.de\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/j%C3%B6rg-engelbergs\/\" target=\"_blank\" rel=\"noopener noreferrer\">Visit Profile<\/a><\/p>\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>J\u00f6rg Engelbergs, PhD Scientific Regulatory Expert Biomedicines at Paul-Ehrlich-Institut (PEI), Federal Institute for Vaccines and Biomedicines<\/p>\n","protected":false},"author":1,"featured_media":33280,"parent":33267,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-33279","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>J\u00f6rg Engelbergs &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Dr. J\u00f6rg Engelbergs is currently working for the Paul-Ehrlich-Institut in Langen, Germany, as regulatory-scientific expert and assessor\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"J\u00f6rg Engelbergs &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Dr. J\u00f6rg Engelbergs is currently working for the Paul-Ehrlich-Institut in Langen, Germany, as regulatory-scientific expert and assessor\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-18T12:32:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/\",\"name\":\"J\u00f6rg Engelbergs &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit.png\",\"datePublished\":\"2020-08-12T14:07:42+00:00\",\"dateModified\":\"2021-03-18T12:32:30+00:00\",\"description\":\"Dr. J\u00f6rg Engelbergs is currently working for the Paul-Ehrlich-Institut in Langen, Germany, as regulatory-scientific expert and assessor\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit.png\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Companion Diagnostics &#038; Biomarkers 2019 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"J\u00f6rg Engelbergs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"J\u00f6rg Engelbergs &#8226; BioTech Pharma Summit","description":"Dr. J\u00f6rg Engelbergs is currently working for the Paul-Ehrlich-Institut in Langen, Germany, as regulatory-scientific expert and assessor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/","og_locale":"en_US","og_type":"article","og_title":"J\u00f6rg Engelbergs &#8226; BioTech Pharma Summit","og_description":"Dr. J\u00f6rg Engelbergs is currently working for the Paul-Ehrlich-Institut in Langen, Germany, as regulatory-scientific expert and assessor","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-03-18T12:32:30+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/","name":"J\u00f6rg Engelbergs &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit.png","datePublished":"2020-08-12T14:07:42+00:00","dateModified":"2021-03-18T12:32:30+00:00","description":"Dr. J\u00f6rg Engelbergs is currently working for the Paul-Ehrlich-Institut in Langen, Germany, as regulatory-scientific expert and assessor","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Engelbergs_Jorg_BioTech_Pharma_Summit.png","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/jorg-engelbergs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Companion Diagnostics &#038; Biomarkers 2019 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/companion-diagnostics-biomarkers-2019-speakers\/"},{"@type":"ListItem","position":3,"name":"J\u00f6rg Engelbergs"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=33279"}],"version-history":[{"count":6,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33279\/revisions"}],"predecessor-version":[{"id":36087,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33279\/revisions\/36087"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33267"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/33280"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=33279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}